Harvard Catalyst Profiles

Contact, publication, and social network information about Harvard faculty and fellows.

Ayman Al Jurdi, M.D.

Concepts (82)

Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
Name Number of Publications Most Recent Publication Publications by All Authors Concept Score Why?
Organ Transplantation6202411741.530 Why?
Kidney Transplantation9202442701.450 Why?
Proteinuria320246071.060 Why?
Measles120241800.780 Why?
Disease Outbreaks2202417590.570 Why?
Bone Diseases120214110.560 Why?
Graft Rejection5202444990.450 Why?
Monitoring, Physiologic1202217920.450 Why?
Antibodies, Monoclonal2202392490.320 Why?
Fractures, Bone1202120410.310 Why?
Antibody Formation2202313910.290 Why?
Glomerular Filtration Rate3202422330.270 Why?
Antibodies, Viral3202332110.270 Why?
Measles Vaccine12024790.220 Why?
Glomerulonephritis, IGA12024620.210 Why?
Glomerulonephritis, Membranous12024840.210 Why?
Budesonide120241630.200 Why?
Enzyme-Linked Immunospot Assay120221260.190 Why?
Isoantibodies220226810.180 Why?
Tacrolimus120247530.180 Why?
Vaccination2202434260.180 Why?
Delayed-Action Preparations120249670.170 Why?
Interleukin-22202418960.170 Why?
Minerals120212780.160 Why?
Vaccines, Synthetic120226210.160 Why?
Hepatitis B120237070.150 Why?
Immunity, Humoral120226050.140 Why?
Transplantation, Homologous2202448600.140 Why?
Piracetam12016880.130 Why?
Immunity, Cellular1202215550.130 Why?
Neurocysticercosis12016880.120 Why?
Humans1920247659680.110 Why?
Tissue Donors1202323950.110 Why?
Cholangiocarcinoma120195780.110 Why?
Antibodies, Neutralizing1202320100.100 Why?
Graft Survival4202438900.100 Why?
Epstein-Barr Virus Infections120196170.100 Why?
Immunosuppressive Agents1202442090.100 Why?
Prospective Studies42024548020.090 Why?
Recurrence1202485010.090 Why?
Renal Insufficiency, Chronic1202423100.080 Why?
Retrospective Studies62024815140.080 Why?
Bone Density1202134910.070 Why?
Carcinoma1201923120.070 Why?
Disease Progression12024136320.070 Why?
Anticonvulsants1201619210.070 Why?
Plasmapheresis120222050.050 Why?
Kidney Function Tests120246830.050 Why?
Epilepsy1201633200.040 Why?
Antilymphocyte Serum120224930.040 Why?
Germinal Center120223790.040 Why?
Qatar12016400.030 Why?
T-Lymphocytes, Helper-Inducer120229750.030 Why?
Retroperitoneal Neoplasms120193350.030 Why?
Middle Aged420242230090.030 Why?
Hepatitis B, Chronic120194120.030 Why?
Fatal Outcome1201918310.030 Why?
Glucocorticoids1202421320.030 Why?
Antibodies1202224170.030 Why?
Male520243636980.030 Why?
Herpesvirus 4, Human1201910780.030 Why?
Neoplasms12022223400.030 Why?
Aged220241711170.030 Why?
Female520243961120.030 Why?
Diagnosis, Differential22019129760.030 Why?
Kidney Failure, Chronic1202424950.020 Why?
Pilot Projects1202487330.020 Why?
Adult520242230440.020 Why?
T-Lymphocytes, Regulatory1202431110.020 Why?
Survival Rate12024127950.020 Why?
Kidney1202370660.020 Why?
Mice22024818190.020 Why?
Incidence12024214800.020 Why?
Treatment Outcome22024651880.010 Why?
Liver Neoplasms1201943530.010 Why?
Prognosis12024299220.010 Why?
Follow-Up Studies12024391930.010 Why?
Postoperative Complications12024157470.010 Why?
Animals220241687640.010 Why?
Neoplasm Recurrence, Local1201993730.010 Why?
Risk Factors12024748400.010 Why?
Young Adult12016598890.010 Why?
Al Jurdi's Networks
Click the
Explore
buttons for more information and interactive visualizations!
Concepts (82)
Explore
_
Co-Authors (29)
Explore
_
Similar People (60)
Explore
_
Same Department 
Explore
_
Funded by the NIH National Center for Advancing Translational Sciences through its Clinical and Translational Science Awards Program, grant number UL1TR002541.